Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Mar 22:13:868863.
doi: 10.3389/fphar.2022.868863. eCollection 2022.

Investigating the Implications of CFTR Exon Skipping Using a Cftr Exon 9 Deleted Mouse Model

Affiliations

Investigating the Implications of CFTR Exon Skipping Using a Cftr Exon 9 Deleted Mouse Model

Kelly M Martinovich et al. Front Pharmacol. .

Abstract

Introduction: Severity and disease progression in people with Cystic Fibrosis (CF) is typically dependent on their genotype. One potential therapeutic strategy for people with specific mutations is exon skipping with antisense oligonucleotides (AO). CFTR exon 9 is an in-frame exon and hence the exclusion of this exon would excise only 31 amino acids but not alter the reading frame of the remaining mRNA. Splice mutations 1209 + 1 G > C and 1209 + 2 T > G were documented to cause CFTR exon 9 skipping and these variants were reported to manifest as a milder CF disease, therefore exon 9 skipping could be beneficial for people with class I mutations that affect exon 9 such as p.Trp401X. While the impact of exon 9 skipping on gene expression and cellular pathways can be studied in cells in vitro, trace amount of full-length normal or mutated material could confound the evaluation. To overcome this limitation, the impact of CFTR exon 9 skipping on disease phenotype and severity is more effectively evaluated in a small animal model. It was hypothesised that antisense oligonucleotide-mediated skipping this particular exon could result in a "mild mouse CF phenotype". Methods: Cftr exon 9 deleted mice were generated using homologous recombination. Survival of homozygous (Cftr Δ9/Δ9 ) and heterozygous (Cftr Δ9/+ ) mice was compared to that of other CF mouse models, and lung and intestinal organ histology examined for any pathologies. Primary airway epithelial cells (pAECs) were harvested from Cftr Δ9/Δ9 mice and cultured at the Air Liquid Interface for CFTR functional assessment using Ussing Chamber analysis. Results: A Cftr Δ9/Δ9 mouse model presented with intestinal obstructions, and at time of weaning (21 days). Cftr Δ9/Δ9 mice had a survival rate of 83% that dropped to 38% by day 50. Histological sections of the small intestine from Cftr Δ9/Δ9 mice showed more goblet cells and mucus accumulation than samples from the Cftr Δ9/+ littermates. Airway epithelial cell cultures established from Cftr Δ9/Δ9 mice were not responsive to forskolin stimulation. Summary: The effect of Cftr exon 9 deletion on Cftr function was assessed and it was determined that the encoded Cftr isoform did not result in a milder "mouse CF disease phenotype," suggesting that Cftr exon 9 is not dispensable, although further investigation in human CF pAECs would be required to confirm this observation.

Keywords: cystic fibrosis transmembrane conductance regulator; exon deletion; exon skipping therapy; mouse model; transgenic mouse.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

FIGURE 1
FIGURE 1
Survival plot of Cftr Δ9/Δ9 mice. At time of weaning (21 days) Cftr Δ9/Δ9 mice had a survival of 83% which dropped to 38% by day 50, with most mice succumbing to intestinal obstruction or malnutrition (solid line). Heterozygous mice did not show decreased survival with 89% survival at day 50 until day 150 when monitoring ended (dashed line). n = 24.
FIGURE 2
FIGURE 2
Hematoxylin and Eosin and Alcian Blue staining of representative lung and intestinal sections from Cftr Δ9/Δ9 and Cftr Δ9/+ (control) mice. (A–F) Hematoxylin and Eosin stained (A). Lung section for Cftr Δ9/Δ9 mouse. (B). Lung section for Cftr Δ9/+ mouse. (C). Small intestinal section from Cftr Δ9/Δ9 mouse. (D). Intestinal section from Cftr Δ9/+ mouse. (E). Crypts of Lieberkühn section from Cftr Δ9/Δ9 mouse. (F). Lieberkühn section from Cftr Δ9/+ mouse. (G–J) Alcain blue stained (G). a Cftr Δ9/Δ9 mouse and (H). Cftr Δ9/+ mouse showing Crypts of Lieberkühn. Sections of small intestine from (I). Cftr Δ9/Δ9 mouse and (J). Cftr Δ9/+ mouse, showing goblet cells. n = 4. Images (A,B), (E–H) were taken at ×40 (scale bar 20 micrometres) and (C,D), (I,J) were taken at ×20 (scale bar 50 micrometres).
FIGURE 3
FIGURE 3
CftrΔ9/Δ9 deleted airway epithelial cell morphology. (A). Airway epithelial cells grown in monolayer had standard cobble stone appearance. Scale bar: 30 micrometres (B). Airway epithelial cells grown at the air-liquid interface with the dense packed growth morphology. Scale bar 30 micrometres. n = 4.
FIGURE 4
FIGURE 4
Cftr Δ9/Δ9 epithelial cell CFTR function. (A,B). Ussing chamber tracing showing change in short circuit current (Isc) in response to drug stimulation on Cftr Δ9/Δ9 ALI cultures pre-treated for 24 h with DMSO. (C,D). Ussing chamber tracing showing change in Isc in response to drug stimulation on homozygote Cftr exon 9 deleted ALI cultures pre-treated for 24 h with Lumacaftor. (E). Summary of changes in Isc in response to amiloride, forskolin and CFTR inhibitor-172 for Cftr Δ9/Δ9 ALI cultures pre-treated with DMSO (Black bars) or Lumacaftor (Grey bars) (Isc, n = 2). Pre-treatment with DMSO (black bar) pre-treatment with Lumacaftor (blue bar), Amiloride addition (green bar), Forskolin stimulation (yellow bar), Ivacaftor stimulation (orange bar), CFTR inhibitor-172 (CI-red bar).

References

    1. Clarke L. L., Grubb B. R., Yankaskas J. R., Cotton C. U., McKenzie A., Boucher R. C. (1994). Relationship of a Non-cystic Fibrosis Transmembrane Conductance Regulator-Mediated Chloride Conductance to Organ-Level Disease in Cftr(-/-) Mice. Proc. Natl. Acad. Sci. U S A. 91 (2), 479–483. 10.1073/pnas.91.2.479 - DOI - PMC - PubMed
    1. Colledge W. H., Abella B. S., Southern K. W., Ratcliff R., Jiang C., Cheng S. H., et al. (1995). Generation and Characterization of a delta F508 Cystic Fibrosis Mouse Model. Nat. Genet. 10 (4), 445–452. 10.1038/ng0895-445 - DOI - PubMed
    1. Cottart C. H., Bonvin E., Rey C., Wendum D., Bernaudin J. F., Dumont S., et al. (2007). Impact of Nutrition on Phenotype in CFTR-Deficient Mice. Pediatr. Res. 62 (5), 528–532. 10.1203/PDR.0b013e318155a61d - DOI - PubMed
    1. Davidson D. J., Rolfe M. (2001). Mouse Models of Cystic Fibrosis. Trends Genet. 17 (10), S29–S37. 10.1016/s0168-9525(01)02452-0 - DOI - PubMed
    1. Gaikwad A., Khan S., Kadam S., Kadam K., Dighe V., Shah R., et al. (2018). The CFTR Gene Mild Variants Poly-T, TG Repeats and M470V Detection in Indian Men with Congenital Bilateral Absence of Vas Deferens. Andrologia 50 (2), e12858. 10.1111/and.12858 - DOI - PubMed

LinkOut - more resources